Skip to main content
Equibles
GMED logo

GMED · Globus Medical Inc

Track GMED — free

Use GMED with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$80.66 +0.18 (+0.22%) At close · Sep 2
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.76B
Shares
134.26M

GMED metrics

81 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$80.66
Market cap
$10.76B

Price action

19 metrics
Price change (1W)
-3.0%
Price change (30D)
-1.2%
Price change (3M)
+2.8%
Price change (6M)
-12.2%
Price change (YTD)
-7.8%
Price change (1Y)
+31.4%
Trailing year
Price change (5Y)
-2.6%
52-week high
$96.82
52-week low
$55.10
Change from 52-week high
-16.9%
Change from 52-week low
+46.1%
Annualized volatility
48.8%
Beta
0.8
RSI (14D)
42.9
Price vs SMA 50
-0.9%
Price vs SMA 200
-6.4%
Avg volume (3M)
1.61M
Relative volume
0.7
Average dollar volume
$129.38M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
134.26M

Valuation

12 metrics
P / E (TTM)
20.7
Trailing earnings · reciprocal yield 4.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.2%
P / book
2.3
reciprocal yield 44.3%
FCF yield
7.0%
TTM · current market cap
Buyback yield
2.1%
P / FCF
14.2
reciprocal yield 7.0%
P / operating cash flow
11.8
reciprocal yield 8.5%
Earnings yield
5.0%

Historical valuation

8 metrics
P / E historical average (3Y)
77.1×
reciprocal yield 1.3%
P / E historical average (5Y)
61.5×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
20.3%
Trailing 12 months
Net margin
17.0%
Gross profit (TTM)
$1.33B
Operating profit (TTM)
$639.52M
Net income (TTM)
$535.43M
Trailing 12 months
Diluted EPS (TTM)
$3.89
FCF margin
24.0%
Effective tax rate
18.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.89

Growth

11 metrics
Revenue growth YoY
+5.9%
Year over year
Net income growth YoY
-25.3%
Revenue (TTM)
$3.14B
Trailing 12 months
EPS growth YoY
-26.2%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+42.2%
Revenue CAGR (5Y)
+30.1%
EPS CAGR (3Y)
+28.4%
EPS CAGR (5Y)
+31.2%
FCF CAGR (3Y)
+78.0%
FCF CAGR (5Y)
+34.2%

Quality

14 metrics
Return on equity
11.2%
Return on assets
9.8%
Debt / equity
—
Current ratio
4.6
EBITDA (TTM)
$919.44M
Free cash flow (TTM)
$755.59M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
-0.6
Return on invested capital
—
Trailing 12 months
Net cash
$595.14M
Latest balance sheet
Cash & equivalents
$507.75M
Total assets
$5.49B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$910.39M
Capital expenditures (TTM)
$154.80M
R&D (TTM)
$147.06M
SG&A (TTM)
$1.22B
Stock compensation (TTM)
$48.96M
R&D / revenue
4.7%
Stock compensation / revenue
1.6%

Ownership (13F)

3 metrics
13F filers
602
13F filer change QoQ
-6
Institutional ownership
89.0%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.20M
Insider-sentiment score
25 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1237831 CUSIP 379577208 13F (30d) 407 filings 393 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)